2019 Highlights

- APRIL 2019
The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies
Campbell, JD, Perry R, et al.Clinical and Translational Allergy 2019 9:21
Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force
Roche, N, Campbell JD, Krishnan JA, et al. Clinical and Translational Allergy 2019 9:20

- MARCH 2019
Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
Batard T, Sanjuan A, et al. Clinical and Translational Allergy 2019 9:13
Evaluation of major mite allergens from European standardized commercial extracts for in vivo diagnosis: addressing the need for precision medicine
González-Pérez R, Poza-Guedes P, et al. Clinical and Translational Allergy 2019 9:14

The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper
N. Fyhrquist, T. Werfel, M. B. Bilò, N. Mülleneisen and R. Gerth van Wijk. Clinical and Translational Allergy 2019 9:3
A specific synbiotic-containing amino acid-based formula in dietary management of cow’s milk allergy: a randomized controlled trial
Adam T. Fox, Harm Wopereis, Marleen T. J. Van Ampting, et al. Clinical and Translational Allergy 2019 9:5

- JANUARY 2019
Dual exposure to smoking and household air pollution is associated with an increased risk of severe asthma in adults in Brazil
Fernandes AGO, Souza-Machado C, Pinheiro GP, et al. Clinical and Translational Allergy 2018 8:48

Relationship between vitamin D and chronic spontaneous urticaria: a systematic review
Tuchinda P, Kulthanan K, Chularojanamontri L, et al. Clinical and Translational Allergy 2018 8:51
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback